OPTIMER PHARMACEUTICALS INC·4

May 18, 5:04 PM ET

Poulos Kevin P 4

4 · OPTIMER PHARMACEUTICALS INC · Filed May 18, 2009

Insider Transaction Report

Form 4
Period: 2009-05-15
Poulos Kevin P
Chief Commerical Officer
Transactions
  • Other

    Common stock

    2009-05-15$7.22/sh+1,370$9,8985,470 total
Footnotes (1)
  • [F1]Acquired under the Company's employee stock purchase plan on May 15, 2009.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT